Сравнение
Liraglutide vs. Pramlintid
Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.
Идентичность
Категория
Метаболизм
Метаболизм
Номер CAS
204656-20-2
151126-32-8
Молекулярная масса
3751 g/mol
3949.4 g/mol
Период полувыведения
13 h
нет данных
Последовательность
HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRGнет данных
Механизм действия
Liraglutide
Liraglutide is a synthetic GLP-1 analog with 97% sequence identity to human GLP-1. A fatty-acid side chain (C16) on Lys-26 reversibly binds serum albumin and protects against DPP-4 degradation. GLP-1 receptor activation glucose-dependently stimulates insulin secretion, inhibits glucagon secretion, delays gastric emptying and modulates central satiety.
Pramlintid
Pramlintide mimics the beta-cell hormone amylin, which is co-secreted with insulin. It slows gastric emptying, suppresses postprandial glucagon release and promotes satiety — thereby blunting post-meal blood-glucose spikes.
Доказательная база
Наивысшая доказательность
РКИ на людях
РКИ на людях
Исследования
5
0
из них на людях
4
0
Зафиксированные эффекты
3
2
Открытые противоречия
1
1
Задокументированные нежелательные явления
1
2
Правовой статус
Полные записи
Frequently asked questions
- What is the difference between Liraglutide and Pramlintid?
- Liraglutide is classified as "Метаболизм", while Pramlintid is classified as "Метаболизм". Liraglutide: GLP-1 receptor agonist with a half-life of about 13 hours. The first daily (not weekly) modern GLP-1 RA — approved as Victoza for type 2 diabetes (2010) and Saxenda for obesity (2014). Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Liraglutide or Pramlintid?
- The highest available evidence level is "РКИ на людях" for Liraglutide and "РКИ на людях" for Pramlintid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Liraglutide and Pramlintid in Germany and the United States?
- Германия: Liraglutide — Рецептурный, Pramlintid — Не одобрено. США: Liraglutide — Рецептурный, Pramlintid — Рецептурный. These are factual summaries with source and review date on the individual pages.